TSplus Introduces New Feedback & Roadmap Platform to Enhance the Remote Desktop User Experience 
Think Business, Think Hong Kong strengthens Italy-Hong Kong ties and opens new path for Asian collaboration 
FUTR Announces Q1 2026 Financial Results 
Tenet Reports Third Quarter 2025 Financial Results 
Eguana Announces Third Quarter 2025 Financial Results AskBio Adds CNS Gene Therapy Programs in Parkinson’s Disease and Multiple System Atrophy
Clinical team led by neurological gene therapy expert, Dr. Krystof Bankiewicz, joins AskBio RESEARCH TRIANGLE…
Aeterna Zentaris Expands Orphan Drug Development Pipeline with Targeted Immunosuppressive Therapeutics
– Company licenses exclusive worldwide rights to develop, manufacture and commercialize targeted, highly specific immunosuppressive…
AGTC Announces Pricing of Public Offering of Common Stock and Warrants
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
Adamis Pharmaceuticals and Human Immune Monitoring Center at Stanford University Announce Preliminary Tempol Data in Cells from COVID-19 Patients
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) in…
IceCure Announces a $15 Million Private Placement and Intention to Pursue NASDAQ Listing
Upon closing, the company to meet Nasdaq listing requirements without the need to effect a…
Soleno Therapeutics to Host Key Opinion Leader Meeting on DCCR for the Treatment of Prader-Willi Syndrome
Webinar on Thursday, February 4, at 12:00 PM ET REDWOOD CITY, Calif., Jan. 28, 2021…
COMPASS Pathways plc to participate in Canaccord Genuity’s New Paradigms and Treatment Approaches in Mental Health Conference
George Goldsmith, Chairman & CEO, to deliver opening day keynote on 3 February London, UK,…
Alkahest Announces Peer-Reviewed Publication Demonstrating Safety and Tolerability of GRF6019 in Patients with Mild-to-Moderate Alzheimer’s Disease
GRF6019 was safe and well-tolerated, and patients experienced no cognitive decline and minimal functional decline…
Avicanna Launches RHO Phyto™ Topical Gels in Canada and Initiates Clinical Studies
Deep Tissue Gel RHO Phyto Deep Tissue Gels RHO Phyto Deep Tissue Gels will be…
Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy
New hire helps lead Aquestive’s continued focus on its epinephrine program Provides update on Libervant™…
Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland
DENVER, Jan. 28, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE:…
EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of EYP-1901 for the Treatment of Wet AMD
WATERTOWN, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company…
XORTX Announces Increase to Private Placement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES CALGARY,…
Bavarian Nordic Reports Preliminary Financial Results for 2020
Revenue and EBITDA in line with guidance for 2020. Year-end cash position better than guided…
Cerevel Therapeutics Hosts Inaugural Virtual R&D Event to Review Darigabat (CVL-865) and Provide Overview of Key Preclinical Programs
Darigabat now the international nonproprietary name (INN) for CVL-865, a Phase 2 GABA Positive Allosteric…
Trevena, Inc. Announces Publication Highlighting OLINVYK™ Respiratory Safety Data in High-Risk Patients in Pain & Therapy
— Low incidence of respiratory depression observed with OLINVYK (oliceridine) injection regardless of age or…
AzurRx BioPharma Announces Completion of Enrollment in First Cohort of Phase 2b OPTION 2 Extension Study of MS1819
DELRAY BEACH, Fla., Jan. 28, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (“AzurRx” or the…
Global WholeHealth Partners Corp. (OTC:GWHP) Announces That It has Signed an Agreement with Charles Strongo for the Right to Sell and Manufacture Biodegradable Plastic for Medical Devices
Global Wholehealth Partners Corp. is Preparing Itself to be the First Fully Green Medical Device…
Nevakar and Théa Enter into Licensing Agreement for the Commercialization of NVK-002 (Atropine for the Treatment of the Progression of Myopia in Children) in Europe
— Potential to receive up to $135 million upon the successful attainment of several key…
Orchard Therapeutics Outlines Comprehensive Presence at 2021 WORLDSymposium™
Nine abstracts accepted demonstrating potential of HSC gene therapy to treat multiple neurodegenerative disorders New…